Cargando…
Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies
OBJECTIVES: To evaluate interest in and patterns of use of non-prescription cannabis products for symptom management amongst gynecologic cancer patients living in states with legal access to medical and recreational marijuana. METHODS: Cross-sectional study using a novel 35-question survey distribut...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804884/ https://www.ncbi.nlm.nih.gov/pubmed/31692541 http://dx.doi.org/10.1016/j.gore.2019.100497 |
_version_ | 1783461281866448896 |
---|---|
author | Blake, Erin A. Ross, Megan Ihenacho, Ugonna Figueroa, Lizzette Silverstein, Emily Flink, Dina Mendez-Ishizaki, Yumi Yessaian, Annie Brunette, Laurie L. Matsuo, Koji Cortessis, Victoria K. Guntupalli, Saketh Roman, Lynda |
author_facet | Blake, Erin A. Ross, Megan Ihenacho, Ugonna Figueroa, Lizzette Silverstein, Emily Flink, Dina Mendez-Ishizaki, Yumi Yessaian, Annie Brunette, Laurie L. Matsuo, Koji Cortessis, Victoria K. Guntupalli, Saketh Roman, Lynda |
author_sort | Blake, Erin A. |
collection | PubMed |
description | OBJECTIVES: To evaluate interest in and patterns of use of non-prescription cannabis products for symptom management amongst gynecologic cancer patients living in states with legal access to medical and recreational marijuana. METHODS: Cross-sectional study using a novel 35-question survey distributed to women diagnosed with gynecologic cancer within two academic centers in California and Colorado. The survey queries demographic and disease traits, and both objective and subjective issues surrounding use of cannabis products for symptom management. Surveys were distributed to patients actively receiving treatment or under surveillance. RESULTS: Enrollment began July 16, 2018 and was completed December 1, 2018. Survey return rate was 52.7%. A total of 225 participants met inclusion criteria. Sixty-two percent reported that they have used or would be interested in using cannabis products for symptom management; 60 (26.7%) are using non-prescription cannabis for treatment of cancer related symptoms, and 80 (35.6%) are interested in using cannabis derivatives under direction of their oncologist. Reasons cited for use of cannabis included: pain control (n = 41, 68.3), insomnia (n = 33, 55.0%), anxiety (n = 29, 48.3%), nausea (n = 26, 43.3%), and appetite stimulation (n = 21, 35.0%). Of the women using cannabis products, almost half report decreased prescription narcotic use after initiation of cannabis products (n = 27, 45.0%). CONCLUSIONS: Women with gynecologic cancer report a strong interest in the use of non-prescription cannabis products for management of cancer-related symptoms. Practitioners in the field of gynecologic oncology should be aware of the frequency of use of non-prescription cannabis amongst their patients as well as the growing desire for guidance about the use of cannabis derivatives. A substantial number of patients report decreased reliance on opioids when using cannabis derivatives for pain control. |
format | Online Article Text |
id | pubmed-6804884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68048842019-11-05 Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies Blake, Erin A. Ross, Megan Ihenacho, Ugonna Figueroa, Lizzette Silverstein, Emily Flink, Dina Mendez-Ishizaki, Yumi Yessaian, Annie Brunette, Laurie L. Matsuo, Koji Cortessis, Victoria K. Guntupalli, Saketh Roman, Lynda Gynecol Oncol Rep Survey Article OBJECTIVES: To evaluate interest in and patterns of use of non-prescription cannabis products for symptom management amongst gynecologic cancer patients living in states with legal access to medical and recreational marijuana. METHODS: Cross-sectional study using a novel 35-question survey distributed to women diagnosed with gynecologic cancer within two academic centers in California and Colorado. The survey queries demographic and disease traits, and both objective and subjective issues surrounding use of cannabis products for symptom management. Surveys were distributed to patients actively receiving treatment or under surveillance. RESULTS: Enrollment began July 16, 2018 and was completed December 1, 2018. Survey return rate was 52.7%. A total of 225 participants met inclusion criteria. Sixty-two percent reported that they have used or would be interested in using cannabis products for symptom management; 60 (26.7%) are using non-prescription cannabis for treatment of cancer related symptoms, and 80 (35.6%) are interested in using cannabis derivatives under direction of their oncologist. Reasons cited for use of cannabis included: pain control (n = 41, 68.3), insomnia (n = 33, 55.0%), anxiety (n = 29, 48.3%), nausea (n = 26, 43.3%), and appetite stimulation (n = 21, 35.0%). Of the women using cannabis products, almost half report decreased prescription narcotic use after initiation of cannabis products (n = 27, 45.0%). CONCLUSIONS: Women with gynecologic cancer report a strong interest in the use of non-prescription cannabis products for management of cancer-related symptoms. Practitioners in the field of gynecologic oncology should be aware of the frequency of use of non-prescription cannabis amongst their patients as well as the growing desire for guidance about the use of cannabis derivatives. A substantial number of patients report decreased reliance on opioids when using cannabis derivatives for pain control. Elsevier 2019-09-09 /pmc/articles/PMC6804884/ /pubmed/31692541 http://dx.doi.org/10.1016/j.gore.2019.100497 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Survey Article Blake, Erin A. Ross, Megan Ihenacho, Ugonna Figueroa, Lizzette Silverstein, Emily Flink, Dina Mendez-Ishizaki, Yumi Yessaian, Annie Brunette, Laurie L. Matsuo, Koji Cortessis, Victoria K. Guntupalli, Saketh Roman, Lynda Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title | Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title_full | Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title_fullStr | Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title_full_unstemmed | Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title_short | Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
title_sort | non-prescription cannabis use for symptom management amongst women with gynecologic malignancies |
topic | Survey Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804884/ https://www.ncbi.nlm.nih.gov/pubmed/31692541 http://dx.doi.org/10.1016/j.gore.2019.100497 |
work_keys_str_mv | AT blakeerina nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT rossmegan nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT ihenachougonna nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT figueroalizzette nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT silversteinemily nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT flinkdina nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT mendezishizakiyumi nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT yessaianannie nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT brunettelauriel nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT matsuokoji nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT cortessisvictoriak nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT guntupallisaketh nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies AT romanlynda nonprescriptioncannabisuseforsymptommanagementamongstwomenwithgynecologicmalignancies |